Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP- dependent protein kinaes pathways

AIDS Research and Human Retroviruses

Volumn 14, Issue 10, 1998, Pages 825-833

  Zidovetzki, Raphael ^a   Wang, Jin Lin ^b   Chen, Peijia ^b   Jeyaseelan, Raju ^b   Hofman, Florence ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 6; MESSENGER RNA; PROTEIN KINASE C; TRANSACTIVATOR PROTEIN;

AIDS RELATED COMPLEX; ARTICLE; BLOOD BRAIN BARRIER; DEMENTIA; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

EID: 0032504015     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.825     Document Type: Article

References (68)

1. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, and Cleary P: The brain in AIDS: Central nervous system and AIDS dementia complex. Science 1988;239:586-592.
2. Smith TW, DeGuolami U, Henin D, Bolgert F, and Hauw JJ: Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 1990;49:357-370.
3. Power C, Kong P-A, Crawford TO, Wesselingh S, Glass JD, McArthur JC, and Trapp BD: Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann Neurol 1993;34:339-350.
4. Kato T, Hirano A, Llena J, and Dembitzer H: Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinuclear giant cells. Acta Neuropathol 1987;73:287-294.
5. Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, and Dickson D: HIV-1 infection of the nervous system: An autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1990;22:700-710.
6. Pumarola-Sune T, Navia B, and Cordon-Cardo C: HIV antigen in the brain of patients with AIDS dementia complex. Ann Neurol 1987;21:490-496.
7. Achim C, Schrier R, and Wiley C: Immunopathogenesis of HIV encephalitis. Brain Pathol 1991;1:177-184.
8. Fauci AS: The human immunodeficiency virus type I: Infectivity and mechanism of pathogenesis. Science 1988;239:617-622.
9. Arya SK, Guo C, Josephs SF, and Wong-Staal F: Trans-activator gene of human T-lymphocyte virus type III (HTLV-III). Science 1985;229:69-73.
10. Dayton AI, Sodroski JG, Rosen CA, Goh WC, and Haseltine WA: The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 1986;44:941-947.
11. Wright CM, Felber BK, Paskalis H, and Pavlakis GN: Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 1986;234:988-992.
12. Rodman TC, Pruslin FH, To SE, and Winston R: Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope. J Exp Med 1992;175:1247-1253.
13. Frankel AD and Pabo CO: Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193.
14. Ensoli B, Barillari G, Salahuddin CZ, Gallo RC, and Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 1990;345:84-86.
15. Ensoli B, Buonagoro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, and Gallo RC: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J Virol 1993;67:277-287.
16. Mann DA and Frankel AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 1991;10:1733-1739.
17. Brake DA, DeBouck C, and Biesecker G: Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency type 1 transactivation protein, Tat. J Cell Biol 1988;111:1275-1281.
18. Barillari G, Gendelman R, Gallo RC, and Ensoli B: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993;90:7941-7945.
19. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, and Walker SM: Exogenous Tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 1994;54:19-28.
20. Breen EC, Razai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, and Marinez-Maza O: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-484.S.
21. Gallo P, Laverda AM, De Rossi A, Pagni S, Del Mistro A, Cogo P, Piccinno MG, Plebani A, Tavolato B, and Chieco-Bianchi L: Immunological markers in the cerebrospinal fluid of HIV-1 infected children. Acta Paediatr Scand 1991;80(6-7):659-666.
22. Sabatier J-M, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, and Bahraoui E: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991;65: 961-967.
23. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, and McCord JM: Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 1993;90:7632-7636.
24. Pocsik E, Higuchi M, and Aggarwal BB: Down-modulation of cell surface expression of p80 form of tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Lymphokine Cytokine Res 1992;11:317-325.
25. Barillari G, Buonaguro L, Filorelli V, Hoffman J, Michael F, Gallo RC, and Ensoli B: Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1994;149: 3727-3734.
26. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, and Barsoum J: Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994;91:664-668.
27. Gwosdow AR, O'Connell NA, and Abou-Samra AB: Interleukin-1 increases protein kinase A activity by a cAMP-independent mechanism in AtT-20 cells. Am J Physiol 1994;266:E79-E84.
28. Yoshimura M and Cooper DMF: Type specific stimulation of adenylyl cyclase by protein kinase C. J Biol Chem 1993;268:4604.
29. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, and Walker SM: Exogenous Tat protein activates human endothelial cells. Blood 1993;82:2774-2780.
30. Westendorp MO, Li-Weber M, Frank RW, and Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994;68:4177-4185.
31. Cupp C, Taylor JP, Khalili K, and Amini S: Evidence for stimulation of the transforming growth factor B1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 1993;8:2231-2236.
32. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang H-K, Brady JN, and Gallo RC: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (London) 1994;371: 674-688.
33. Albini A, Barillari G, Benelli R, Gallo RC, and Ensoli B: Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995;92:483-442.
34. Ambrosino C, Ruocco MR, Chen X, Mallardo M, Baudi F, Trematerra S, Quinto F, Venuta S, and Scala G: HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J Biol Chem 1997;272(23): 14883-14892.
35. Kozawa O, Suzuki A, Tokuda H, and Uematsu T: Prostaglandin F2 alpha stimulated interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol 1997;272(2Pt1):E208-211.
36. Nishizuka Y: Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258: 607-614.
37. Chirmule N, Than S, Khan SA, and Pahwa S: Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol 1995;69:492-498.
38. Hofmann B, Nishanian P, Nguen T, Insixiengmay P, and Fahey JL: Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci USA 1993;90:6676-6680.
39. Jacobovits A, Rosenthal A, and Capon DJ: Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. EMBO J 1990;9:1165-1170.
40. Schleimer RP and Rutledge BK: Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 1986;136:649-654.
41. Lane TA, Lamkin GE, and Wancewicz E: Biochem Biophys Res Commun 1989;161:945-952.
42. Ritchie AJ, Johnson DR, Ewenstein BM, Pober JS: Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporin. J Immunol 1991;146: 3056-3062.
43. Myers CL, Desai SN, Schembri-King J, Letts GL, and Wallace RW: Discriminatory effects of protein kinase inhibitors and calcium ionophore on endothelial ICBM-1 induction. Am J Physiol C 1992;262(2Pt1):C365-373.
44. Wertheimer ST, Myers CL, Wallace RW, and Parks T: Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-α and phorbol myristate acetate. J Biol Chem 1992;267:12030-12035.
45. Turunen JP, Ustinov J, and Renkonen R: Adhesion molecules involved in protein kinase A- and C-dependent lymphocyte adherence to microvascular endothelial cells. Scand J Immunol 1993;37(3):282-288.
46. Manila P, Majuri M-L, Mattila PS, and Renkonen R: TNFα-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand J Immunol 1992;36:159-165.
47. Kooistra T, Bosma PJ, Toet K, Cohen LH, Griffioen M, van den Berg E, le Clercq L, and van Hinsbergh: Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells.Arteriosclerosis Thrombosis 1991;11:1042-1052.
48. Montesano R and Orci L: Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 1985;42:469-477.
49. Araki S, Shimada Y, Kaji K, and Hayashi H: Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun 1990;172:1081-1085.
50. Hoshi H, Kan M, Mioh H, Chen J, and McKeehan WL: Phorbol ester reduces number of heparin-binding growth-factor receptors in human adult endothelial cells. FASEB J. 1988;2:2797-2800.
51. Lane TA, Lamkin GE, and Wancewicz EV: Protein kinase C inhibitors block the enhanced expression of intercellular adhesion molecule-1 on endothelial cells activated by interleukin-1, lipopolysaccharide and tumor necrosis factor. Biochem Biophys Res Commun 1990;172:1273-1281.
52. Santell L and Levin EG: Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator-1 from human endothelial cells. J Biol Chem 1988;263:16802-16808.
53. Carson MR, Shasby SS, and Shasby DM: Histamine and inositol phosphate accumulation in endothelium: cAMP and a G protein. Am J Physiol 1989;257:L259-L264.
54. Hoek JB: Editorial: Intracellular signal transduction and the control of endothelial permeability. Lab Invest 1992;67:1-4.
55. Francis SH and Corbin JD: Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 1994;56: 237-272.
56. Spaulding SW: The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocrine Rev 1993;14: 632-650.
57. s-GTP-catalytic interaction. J Biol Chem 1985;260:2625-2628.
58. Rebois RV and Patel J: Phorbol ester causes desensitization of gonadotropin-responsive adenylate cyclase in a murine Leydig tumor cell line. J Biol Chem 1985;260:8026-8031.
59. Manolopoulos VG, Liu J, Unsworth BR, and Lelkes PI: Adenylyl cyclase isoforms are differentially expressed in primary cultures of endothelial cells and whole tissue homogenates from various rat tissues. Biochem Biophys Res Commun 1985;208:323-331.
60. Stanimirovic DB, Yamamoto T, Uematsu S, and Spatz M: Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J Neurochem 1994;62: 592-601.
61. Cook SJ and McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993;262:1069-1077.
62. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, and Sturgill TW: Inhibition of the EGF-activated MAP kinase signalling pathway by adenosine 3′,5′-monophosphate. Science 1993;262: 1065-1069.
63. Sehgal PB, Walther Z, and Tamm I: Rapid enhancement of β2-interferon/B cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerol and the calcium ionophore A23187. Proc Natl Acad Sci USA 1987;84:3663-3667.
64. Zhang Y, Lin J-X, and Viliek J: Synthesis of interleukin 6 (interferon β2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988;263:6177-6182.
65. Zhang Y, Lin J-X, and Viliek J: Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a κB-like sequence. Mol Cell Biol 1990;10:3818-3823.
66. Duchini A, Govindarajan S, Sanlucci M, Zampi G, and Hofman FM: Effects of tumor necrosis factor-α and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Invest Med 1996;44:474-482.
67. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, and Fontana A: On the cellular source and function of interleukin 6 in the central nervous system in viral diseases. Eur J Immunol 1989;19:689-694.
68. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, and Sehgal PB: Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 1989; 170:1649-1669.